Gun Shih Ying, Moosa Aminath Shiwaza, Poh Chen Wei, Ng Sherryl Lei, Tan Ngiap Chuan
SingHealth Polyclinics, Singapore 150167, Singapore.
SingHealth Duke-NUS Family Medicine Academic Clinical Programme, Singapore 150167, Singapore.
Vaccines (Basel). 2023 Mar 1;11(3):565. doi: 10.3390/vaccines11030565.
(1) Background: Child influenza vaccine uptake is suboptimal due partly to vaccine hesitancy. A voice-annotated digital decision aid, Flu Learning Object (FLO), was developed to facilitate parental decision-making. This study assessed parental views on FLO's usability and utility and determined its preliminary effectiveness in increasing vaccine intention and uptake; (2) Methods: A single-center mixed method study was conducted in a public primary care clinic in Singapore. Parents of children aged 6 months to 5 years who were unvaccinated in the preceding year were recruited. In-depth interviews explored their views of using FLO. Pre- and post-FLO questionnaires assessed their vaccine intention and perceived usability using the System Usability Scale (SUS); (3) Results: 18 parents were recruited. They became more aware of benefits and potential complications, distinguished influenza from the common cold, and recognized recommendations by National Childhood Immunisation Schedule. FLO addressed parents' concerns and supported their decision-making process. FLO has good usability with a mean SUS score of 79.3, ranked at approximately the 85th percentile. The usage of FLO significantly increased vaccine intention from 55.6% to 94.4% ( = 0.016) with an actual vaccine uptake rate of 50%; (4) Conclusions: Parents generally accepted FLO, which positively influenced their intention to vaccinate their child against influenza.
(1) 背景:儿童流感疫苗接种率未达最佳水平,部分原因是疫苗犹豫。开发了一种带有语音注释的数字决策辅助工具——流感学习对象(FLO),以促进家长的决策。本研究评估了家长对FLO可用性和实用性的看法,并确定其在提高疫苗接种意愿和接种率方面的初步效果;(2) 方法:在新加坡一家公立基层医疗诊所进行了一项单中心混合方法研究。招募了前一年未接种疫苗的6个月至5岁儿童的家长。深入访谈探讨了他们对使用FLO的看法。FLO前后的问卷使用系统可用性量表(SUS)评估了他们的疫苗接种意愿和感知可用性;(3) 结果:招募了18名家长。他们更加了解了疫苗的益处和潜在并发症,区分了流感和普通感冒,并认可了国家儿童免疫规划的建议。FLO解决了家长的担忧并支持了他们的决策过程。FLO具有良好的可用性,平均SUS评分为79.3,排名约为第85百分位。FLO的使用显著提高了疫苗接种意愿,从55.6%提高到94.4%(P = 0.016),实际疫苗接种率为50%;(4) 结论:家长普遍接受FLO,这对他们为孩子接种流感疫苗的意愿产生了积极影响。